|Day Low/High||51.32 / 51.90|
|52 Wk Low/High||36.28 / 80.66|
The Nasdaq and S&P 500 hover at record highs.
Teva has a path to complete the deal.
The shares of drugmaker Akorn are rising after Israeli pharmaceutical company Teva earlier today made a takeover bid for another company in the space, generic drugmaker Mylan.
Mylan's deal to buy Perrigo is taking another potential target off the block.
On the heels of Nokia's proposed Alcatel Lucent purchase, here's a closer look at what to do with a stock after a M&A, regardless of whether you already own it.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.
California-based optical firm Infinera plans to purchase an optical-network systems maker, Transmode, with $345M offer, joining this week's swirl of deal activity involving European companies.
Recent activity has heated up and is creating shareholder value.
Trade-Ideas LLC identified Perrigo (PRGO) as an unusual social activity candidate
U.S. stock futures are flat Thursday. Earnings season is underway and investors are still considering Wednesday's big proposed mergers in energy and pharmaceuticals.
The drug companies' strengths in generics and knocks-off drugs should complement one another.
Southwest and Spirit are Cramer's favorite airlines but he says the Royal Dutch Shell deal for BG Group is an 'embarrassment.'
The market got a gift today, says Cramer. So why were investors heading for the hills?
Mylan made public on Wednesday that it had made a proposal to acquire generic drugmaker Perrigo in a deal valued at $205 per share in cash and stock.
The stock markets in the United States fluctuated and eventually ended higher after the Federal Reserve released the minutes of its meeting indicating that policy makers are divided on raising interes...
Wall Street was as divided as the Federal Reserve on Wednesday.
Stocks pop Wednesday as the minutes of the Federal Reserve meeting in March show the central bank divided in its thinking about rate hikes.
Perrigo (PRGO) is gaining Wednesday on Mylan's (MYL) proposal to acquire the company.
Trade-Ideas LLC identified Perrigo (PRGO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.